Angiotensin-converting enzyme insertion/deletion gene polymorphism in patients with familial multiple cerebral cavernous malformations
JOURNAL OF CLINICAL NEUROSCIENCE, vol.17, no.8, pp.1034-1037, 2010 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 17 Issue: 8
- Publication Date: 2010
- Doi Number: 10.1016/j.jocn.2009.12.002
- Journal Name: JOURNAL OF CLINICAL NEUROSCIENCE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1034-1037
- Keywords: Angiotensin-converting enzyme, Familial cerebral cavernous malformations, Polymorphism, ENDOTHELIAL GROWTH-FACTOR, EPITHELIAL-MESENCHYMAL TRANSDIFFERENTIATION, VASCULAR MALFORMATIONS, EMBRYONIC LETHALITY, MUTATIONS, VEGF, EXPRESSION, CELLS, KRIT1, INACTIVATION
- Akdeniz University Affiliated: No
Abstract
Cavernous malformations can occur in both sporadic and autosomal dominant forms. The aim of this study was to investigate the potential role of insertion/deletion (I/D) polymorphisms of the angiotensin-converting enzyme (ACE) gene in the development of cerebral cavernous malformations (CCM). Forty-one members of two families affected by familial CCM were included in this study. DNA was isolated from peripheral venous blood, and polymerase chain reaction analysis was used to detect I/D polymorphisms of the ACE gene, using HACE3s and HACE3as as primers. Only 10 participants had MRI-confirmed CCM. Of these 10 subjects, seven had the I/D, two had the DID, and one had the I/I genotype. Of the remaining 31 subjects, 14 had the I/I, 13 had the I/D, and four had the D/D genotype. There was a greater proportion of subjects with the D allele among those with MRI-confirmed CCM than among those without (p<0.05). These results suggest that the D polymorphism of the ACE gene may be involved in the pathogenesis of familial CCM. (C) 2010 Elsevier Ltd. All rights reserved.